FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

710228002: Ibrutinib (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2015. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3044140010 Ibrutinib (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3044201012 Ibrutinib en Synonym Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ibrutinib Is a Substance with non-specific protein-tyrosine kinase inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Ibrutinib Has disposition Non-specific protein-tyrosine kinase inhibitor true Inferred relationship Existential restriction modifier
Ibrutinib Is a Chemical categorized functionally false Inferred relationship Existential restriction modifier
Ibrutinib Is a Substance with enzyme inhibitor mechanism of action false Inferred relationship Existential restriction modifier
Ibrutinib Is a Acrylamide true Inferred relationship Existential restriction modifier
Ibrutinib Is a Antineoplastic agent true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing ibrutinib Has active ingredient True Ibrutinib Inferred relationship Existential restriction modifier 1
Product containing ibrutinib in oral dose form (medicinal product form) Has active ingredient True Ibrutinib Inferred relationship Existential restriction modifier 1
Ibrutinib Has active ingredient True Ibrutinib Inferred relationship Existential restriction modifier 1
Product containing only ibrutinib in oral dose form (medicinal product form) Has active ingredient True Ibrutinib Inferred relationship Existential restriction modifier 1
Product containing precisely ibrutinib 140 milligram/1 each conventional release oral capsule (clinical drug) Has precise active ingredient True Ibrutinib Inferred relationship Existential restriction modifier 1
Product containing precisely ibrutinib 140 milligram/1 each conventional release oral capsule (clinical drug) Has basis of strength substance True Ibrutinib Inferred relationship Existential restriction modifier 1
Product containing precisely ibrutinib 140 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Ibrutinib Inferred relationship Existential restriction modifier 1
Product containing precisely ibrutinib 140 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Ibrutinib Inferred relationship Existential restriction modifier 1
Product containing precisely ibrutinib 420 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Ibrutinib Inferred relationship Existential restriction modifier 1
Product containing precisely ibrutinib 420 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Ibrutinib Inferred relationship Existential restriction modifier 1
Product containing precisely ibrutinib 560 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Ibrutinib Inferred relationship Existential restriction modifier 1
Product containing precisely ibrutinib 560 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Ibrutinib Inferred relationship Existential restriction modifier 1
Product containing precisely ibrutinib 280 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Ibrutinib Inferred relationship Existential restriction modifier 1
Product containing precisely ibrutinib 280 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Ibrutinib Inferred relationship Existential restriction modifier 1
Ibrutinib 140mg capsules Has active ingredient False Ibrutinib Inferred relationship Existential restriction modifier
Ibrutinib 560mg tablets Has specific active ingredient True Ibrutinib Inferred relationship Existential restriction modifier
Ibrutinib 280mg tablets Has specific active ingredient True Ibrutinib Inferred relationship Existential restriction modifier
Ibrutinib 420mg tablets Has specific active ingredient True Ibrutinib Inferred relationship Existential restriction modifier
Ibrutinib 140mg tablets Has specific active ingredient True Ibrutinib Inferred relationship Existential restriction modifier
Imbruvica 420mg tablets (Janssen-Cilag Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient True Ibrutinib Inferred relationship Existential restriction modifier
Imbruvica 140mg tablets (Janssen-Cilag Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient True Ibrutinib Inferred relationship Existential restriction modifier
Imbruvica 280mg tablets (Janssen-Cilag Ltd) Has specific active ingredient True Ibrutinib Inferred relationship Existential restriction modifier
Imbruvica 280mg tablets (Janssen-Cilag Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient True Ibrutinib Inferred relationship Existential restriction modifier
Imbruvica 140mg tablets (Janssen-Cilag Ltd) Has specific active ingredient True Ibrutinib Inferred relationship Existential restriction modifier
Ibrutinib 280mg tablets 28 tablet Has specific active ingredient True Ibrutinib Inferred relationship Existential restriction modifier
Imbruvica 560mg tablets (Janssen-Cilag Ltd) 28 tablet 2 x 14 tablets Has specific active ingredient True Ibrutinib Inferred relationship Existential restriction modifier
Ibrutinib 280mg tablets Has active ingredient False Ibrutinib Inferred relationship Existential restriction modifier
Ibrutinib 420mg tablets Has active ingredient False Ibrutinib Inferred relationship Existential restriction modifier
Ibrutinib 420mg tablets 28 tablet Has specific active ingredient True Ibrutinib Inferred relationship Existential restriction modifier
Imbruvica 560mg tablets (Janssen-Cilag Ltd) Has specific active ingredient True Ibrutinib Inferred relationship Existential restriction modifier
Ibrutinib 560mg tablets Has active ingredient False Ibrutinib Inferred relationship Existential restriction modifier
Ibrutinib 560mg tablets 28 tablet Has specific active ingredient True Ibrutinib Inferred relationship Existential restriction modifier
Imbruvica 420mg tablets (Janssen-Cilag Ltd) Has specific active ingredient True Ibrutinib Inferred relationship Existential restriction modifier
Ibrutinib 140mg tablets Has active ingredient False Ibrutinib Inferred relationship Existential restriction modifier
Ibrutinib 140mg tablets 28 tablet Has specific active ingredient True Ibrutinib Inferred relationship Existential restriction modifier
Ibrutinib 140mg capsules Has specific active ingredient True Ibrutinib Inferred relationship Existential restriction modifier
Imbruvica 140mg capsules (Janssen-Cilag Ltd) Has specific active ingredient True Ibrutinib Inferred relationship Existential restriction modifier
Ibrutinib 140mg capsules 120 capsule Has specific active ingredient True Ibrutinib Inferred relationship Existential restriction modifier
Ibrutinib 140mg capsules 90 capsule Has specific active ingredient True Ibrutinib Inferred relationship Existential restriction modifier
Imbruvica 140mg capsules (Janssen-Cilag Ltd) 90 capsule Has specific active ingredient True Ibrutinib Inferred relationship Existential restriction modifier
Imbruvica 140mg capsules (Janssen-Cilag Ltd) 120 capsule Has specific active ingredient True Ibrutinib Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start